Liu Y - Search Results

1

Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis.

Zhang Y, Huang P, Liu X, Xiang Y, Zhang T, Wu Y, Xu J, Sun Z, Zhen W, Zhang L, Si Y, Liu Y. Zhang Y, et al. Among authors: liu y, liu x. J Pharmacol Sci. 2018 Jul;137(3):305-312. doi: 10.1016/j.jphs.2018.07.008. Epub 2018 Jul 26. J Pharmacol Sci. 2018. PMID: 30119963 Free article.

2

Expression of cancerous inhibitor of protein phosphatase 2A in human triple negative breast cancer correlates with tumor survival, invasion and autophagy.

Li S, Feng TT, Guo Y, Yu X, Huang Q, Zhang L, Tang W, Liu Y. Li S, et al. Among authors: liu y. Oncol Lett. 2016 Dec;12(6):5370-5376. doi: 10.3892/ol.2016.5374. Epub 2016 Nov 9. Oncol Lett. 2016. PMID: 28101248 Free PMC article.

3

Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.

Huang Q, Qin S, Yuan X, Zhang L, Ji J, Liu X, Ma W, Zhang Y, Liu P, Sun Z, Zhang J, Liu Y. Huang Q, et al. Among authors: liu y, liu x, liu p. Oncol Rep. 2017 Jul;38(1):598-606. doi: 10.3892/or.2017.5667. Epub 2017 May 24. Oncol Rep. 2017. PMID: 28560452

4

Overexpression of SET oncoprotein is associated with tumor progression and poor prognosis in human gastric cancer.

Yuan X, Zhang T, Zheng X, Zhang Y, Feng T, Liu P, Sun Z, Qin S, Liu X, Zhang L, Song J, Liu Y. Yuan X, et al. Among authors: liu y, liu x, liu p. Oncol Rep. 2017 Sep;38(3):1733-1741. doi: 10.3892/or.2017.5788. Epub 2017 Jul 4. Oncol Rep. 2017. PMID: 28677734

5

Oridonin induces apoptosis and reverses drug resistance in cisplatin resistant human gastric cancer cells.

He Z, Xiao X, Li S, Guo Y, Huang Q, Shi X, Wang X, Liu Y. He Z, et al. Among authors: liu y. Oncol Lett. 2017 Aug;14(2):2499-2504. doi: 10.3892/ol.2017.6421. Epub 2017 Jun 19. Oncol Lett. 2017. PMID: 28781688 Free PMC article.

6

Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer.

Ji J, Zhen W, Si Y, Ma W, Zheng L, Li C, Zhang Y, Qin S, Zhang T, Liu P, Zheng X, Liu Y. Ji J, et al. Among authors: liu y, liu p. Cancer Biomark. 2018 Feb 6;21(2):307-316. doi: 10.3233/CBM-170416. Cancer Biomark. 2018. PMID: 29103022

7

Overexpression of CIP2A is associated with poor prognosis in multiple myeloma.

Liu X, Cao W, Qin S, Zhang T, Zheng J, Dong Y, Ming P, Cheng Q, Lu Z, Guo Y, Zhang B, Liu Y. Liu X, et al. Among authors: liu y. Signal Transduct Target Ther. 2017 May 26;2:17013. doi: 10.1038/sigtrans.2017.13. eCollection 2017. Signal Transduct Target Ther. 2017. PMID: 29263916 Free PMC article.

8

Cucurbitacin B induces inhibitory effects via CIP2A/PP2A/Akt pathway in glioblastoma multiforme.

Qin S, Li J, Si Y, He Z, Zhang T, Wang D, Liu X, Guo Y, Zhang L, Li S, Li Q, Liu Y. Qin S, et al. Among authors: liu y, liu x. Mol Carcinog. 2018 Jun;57(6):687-699. doi: 10.1002/mc.22789. Epub 2018 Feb 26. Mol Carcinog. 2018. PMID: 29393542

9

Ethoxysanguinarine inhibits viability and induces apoptosis of colorectal cancer cells by inhibiting CIP2A.

Jin L, Si Y, Hong X, Liu P, Zhu B, Yu H, Zhao X, Qin S, Xiong M, Liu Y, Luo Z, Guo Y. Jin L, et al. Among authors: liu y, liu p. Int J Oncol. 2018 May;52(5):1569-1578. doi: 10.3892/ijo.2018.4323. Epub 2018 Mar 16. Int J Oncol. 2018. PMID: 29568959

10

Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer.

Liu X, Sun Z, Deng J, Liu J, Ma K, Si Y, Zhang T, Feng T, Liu Y, Tan Y. Liu X, et al. Among authors: liu j, liu y. Int J Oncol. 2018 Sep;53(3):1279-1288. doi: 10.3892/ijo.2018.4464. Epub 2018 Jun 29. Int J Oncol. 2018. PMID: 29956727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,278 results

Search Page

Filters